One World Cannabis to Present at Prague Medical Cannabis Conference


Ryan Allway

March 5th, 2015

Top News


Company Will Be Senior Presenter at “Medical Cannabis and Cannabinoids” Conference Held in Prague, Czech Republic

PETACH TIKVA, Israel, March 5, 2015 /PRNewswire/ —

OWC Pharmaceutical Research Corp’s (OTCQB: OWCP) wholly owned subsidiary One World Cannabis Ltd. (“the Company”), an Israeli research and development (R&D) company focused on cannabis-based products and treatments, today announced that it would be a senior presenter at the “Medical Cannabis and Cannabinoids” Conference organized by the Czech Republic Ministry on March 4-7, 2015.

The Medical Cannabis and Cannabinoids conference is designed to assist Czech health care professionals, including doctors, nurses and other medical staff, better understand medical cannabis and cannabinoids. Dr. Yehuda Baruch, One World Cannabis Director of Research and Regulatory Affairs, is hosting four sessions discussing the human endocannabinoid system and the effects of various strains of medical cannabis in the treatment of medical symptoms, as well as dosing concerns like how to start, how long, how and when to stop.

Dr. Tomáš Zábranský, an advisor on drug policy to the Czech Prime Minister and one of the Conference organizers: “Yehuda [Dr. Baruch] is the father and mother of the Czech Republic education programs on medical cannabis for the medical staff. This is the kick-off and he [Dr. Baruch] was extremely helpful in all the preparations of the Conference.”

Prior to joining the Company, Dr. Yehuda Baruch served as Head of the Israeli Ministry of Health’s Medical Cannabis Program from 2003 through 2013, where he spearheaded the efforts on regulation, chaired the indication committee, secured Helsinki Approvals for medical research, and managed regulation of patient licensing and dosage.

The Company’s Research Division, headed by Dr. Baruch, will be focused on developing and conducting studies designed to produce new cannabis-based products for the treatment of various diseases and conditions. In addition to the R&D work, the Company’s Consulting Division provides expert assistance to government officials and regulatory agencies in establishing the infrastructure necessary for the safe care and management of patents using medical cannabis.

Dr. Baruch has extensive experience in researching medical cannabis – most notably for its effect on PTSD. From 2004 until recently, he served as CEO of Abarbanel Mental Health Center in Bat Yam, Israel. Prior to that, he was the Director of Israel’s Ministry of Health medical management division, and Director General of Be’er Yakov Mental Health Center. He has taught at Ben-Gurion University of the Negev andTel Aviv University’s Sackler School of Medicine.

Ziv Turner, CEO at One World Cannabis, commented: “I firmly believe that Dr. Baruch’s unique experience will further establish One World Cannabis as a leading organization in the medical-cannabis field – both in research and development and in regulatory consultant services to international entities.”

About One World Cannabis Ltd.

One World Cannabis Ltd. (“the Company”) is an Israel-based company founded in 2014 by a group of professionals with expertise in the field of medical cannabis (marijuana) treatment and medical cannabis regulatory affairs. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks. The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. (OTCQB: OWCP).

Forward-Looking Statements

This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “anticipates” or other similar words or expressions. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual results to differ materially from such statements. These risks and uncertainties are described in greater detail in OWC Pharmaceutical Research Corp.’s filings with the Securities and Exchange Commission (the “Commission”), including, and without limitation, its annual and periodic reports and other documents filed with the Commission. Unless legally required, OWC Pharmaceutical Research Corp. disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact details:
Ziv Turner
[email protected]
+972-375826657

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading